Rebaudioside A is a novel agent of glycoside clathration of pharmacons, acts as α-glucosidase inhibitor.

Picrasidine I has antiosteoclastogenic effect by inhibiting inflammation induced activation of MAPKs, ROS generation followed by suppressing the gene expression of c-Fos and NFATc1 in osteoclast precursors.

(R)-Benzyl mandelate (D-(-)-Mandelic Acid Benzyl Ester) is a synthetic intermediate useful for pharmaceutical synthesis.